Page last updated: 2024-09-03

elacridar and Cardiotoxicity

elacridar has been researched along with Cardiotoxicity in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakanishi, T; Shinozaki, K; Takeuchi, R; Tamai, I1

Other Studies

1 other study(ies) available for elacridar and Cardiotoxicity

ArticleYear
Local Drug-Drug Interaction of Donepezil with Cilostazol at Breast Cancer Resistance Protein (ABCG2) Increases Drug Accumulation in Heart.
    Drug metabolism and disposition: the biological fate of chemicals, 2016, Volume: 44, Issue:1

    Topics: Acridines; Administration, Intravenous; Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Blood-Brain Barrier; Cardiotoxicity; Cholinesterase Inhibitors; Cilostazol; Dogs; Donepezil; Drug Interactions; Female; In Vitro Techniques; Indans; Madin Darby Canine Kidney Cells; Male; Models, Biological; Myocardium; Piperidines; Rats, Wistar; Tetrahydroisoquinolines; Tetrazoles; Tissue Distribution; Transfection

2016